Holen Sie sich die Stockscreener-App
4.61
8.45%
0.35
Handel nachbörslich:
4.55
-0.06
-1.30%
Exagen Inc Aktie (XGN) Neueste Nachrichten
Exagen Inc. (XGN) Inches Lower as Shares Test Key Support Near $4.05Elliott Wave Entry - Newser
Exagen Inc. Common Stock (XGN) Stock Price Today & Analysis - Gotrade
Exagen Inc. (XGN) Q1 2026 Earnings: Narrower-Than-Expected Loss Drives Positive SurpriseRevenue Per Share - Newser
Earnings call transcript: Exagen Inc. beats Q1 2026 expectations, stock surges - Investing.com Nigeria
Exagen Inc. (XGN) reports Q1 loss, beats revenue estimates - MSN
Exagen Inc stock (US30063K1051): 13G filing shows 9.9% stake - AD HOC NEWS
EXAGEN (XGN) holder Jorey Chernett reports 2.41M shares, 9.9% - Stock Titan
Exagen (XGN) Rallies +8.02% as Bulls Target $3.96 2026-05-19Professional Trade Ideas - Newser
Exagen reaffirms $70M-$73M 2026 revenue guidance as it targets $600-$650 ASP over time - MSN
Record revenue growth and higher test pricing keep Exagen (XGN) in focus despite ongoing losses - MSN
Why Exagen (XGN) Just Dropped -4.55% — What to Watch 2026-05-15TPO Profile - Newser
Exagen Company Profile & Introduction - Moomoo
Exagen Inc. (NASDAQ:XGN) Just Released Its First-Quarter Results And Analysts Are Updating Their Estimates - simplywall.st
The Exagen Inc. (NASDAQ:XGN) First-Quarter Results Are Out And Analysts Have Published New Forecasts - Yahoo Finance
Exagen Targets $73 Million Revenue for 2026 as Test Volumes Surge - HarianBasis.co
Exagen Inc. (NASDAQ:XGN) Q1 2026 Earnings Call Transcript - Insider Monkey
Exagen (XGN) Receives a Buy from BTIG - The Globe and Mail
TradingKey - TradingKey
Exagen Achieves Record Q1 Revenue Driven by AVISE CTD Adoption - HarianBasis.co
Analysts Offer Insights on Healthcare Companies: Exagen (XGN) and Liquidia Technologies (LQDA) - The Globe and Mail
Exagen (XGN) Q1 2026 Earnings Transcript - AOL.com
Exagen Inc stock (US30063K1051): Q1 revenue hits record $17.3M, up 12% - AD HOC NEWS
XGN Maintained by BTIG -- Price Target Lowered to $8.00 - GuruFocus
CCORF Maintains Exagen(XGN.US) With Buy Rating, Maintains Target Price $8 - Moomoo
BTIG Maintains Exagen(XGN.US) With Buy Rating, Cuts Target Price to $8 - Moomoo
Exagen Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
Exagen stock price target lowered to $8 by BTIG on valuation - Investing.com UK
Exagen Inc (XGN) Q1 2026 Earnings Call Highlights: Record Revenue and Strategic Growth Amid Challenges - GuruFocus
Exagen (XGN) Reports Record Q1 Revenue of $17.3 Million, Up 12% Year-Over-Year - GuruFocus
Exagen | 10-Q: Q1 2026 Earnings Report - Moomoo
Number of shareholders of Exagen, Inc. – FWB:E08A - TradingView
Exagen Inc. 2026 Q1ResultsEarnings Call Presentation (NASDAQ:XGN) 2026-05-12 - Seeking Alpha
TD Cowen Maintains Exagen(XGN.US) With Buy Rating, Cuts Target Price to $8 - Moomoo
Is Exagen (XGN) 30.9% Overvalued After Q1 2026 Earnings? EPS -0. - GuruFocus
Exagen Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Exagen Q1 earnings call highlights - MSN
Exagen Q1 Earnings Call Highlights - MarketBeat
XGN Maintains Revenue Forecast for 2026 - GuruFocus
Exagen Inc. Achieves Record $17.3 Million Q1 2026 Revenue - HarianBasis.co
Exagen (XGN) Achieves Strong Q1 Revenue Exceeding Expectations - GuruFocus
Exagen (NASDAQ:XGN) Issues Earnings Results, Beats Estimates By $0.07 EPS - MarketBeat
Exagen Inc. Reaffirms Earnings Guidance for the full year 2026 - marketscreener.com
1.43%
0.39%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):